查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1806218

持續血糖監測系統市場按組件、設備類型、使用時長、患者年齡層、應用、分銷管道和最終用戶分類 - 全球預測 2025-2030

Continuous Glucose Monitoring Systems Market by Component, Type of Device, Duration of Use, Patient Age Group, Application, Distribution Channel, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

持續血糖監測系統市場預計到 2024 年將達到 44.7 億美元，2025 年將達到 47.9 億美元，到 2030 年將達到 68.2 億美元，複合年成長率為 7.26%。

主要市場統計數據
基準年2024年 44.7億美元
預計2025年 47.9億美元
預測年份 2030 68.2億美元
複合年成長率（%） 7.26%

探索持續血糖監測系統作為塑造全球現代糖尿病管理的關鍵力量的出現

近年來，持續血糖監測系統透過提供不間斷的即時血糖值追蹤，重新定義了慢性病管理。這項發展將血糖監測模式從順序指尖採血轉變為持續的數據驅動型方法，使臨床醫生和患者能夠識別趨勢、預測波動並主動干預。隨著糖尿病盛行率持續上升，醫療保健提供者面臨著提供個人化、反應迅速的護理以減少併發症並提高生活品質的挑戰。

宣布突破性進展和整合技術，革新即時血糖監測，改善患者預後

感測器微型化、雲端連接以及預測演算法的整合正在徹底改變血糖監測格局。現代設備不再孤立運行，而是與智慧型手機、雲端資料庫和遠端監控平台無縫整合，使醫療團隊能夠近乎即時地做出回應。這種持續向互通性轉變正在為數據分析開闢新的途徑，提供指導治療調整和降低急性血糖事件風險的見解。

評估關稅對美國持續血糖監測系統成本和供應鏈動態的影響

2025年修訂的關稅措施訂定，凸顯了持續血糖監測系統分銷領域供應鏈的脆弱性。微電子感測器和無線收發器等關鍵零件的進口關稅上調，給製造業帶來了成本壓力。為此，一些供應商已實施多元化籌資策略，將生產設施遷至更靠近終端市場的地方，或協商替代原料契約，以緩解運費和關稅上漲的影響。

根據組件、設備類型、使用時長、患者人口統計、應用和分銷管道進行市場細分

仔細研究連續血糖監測系統的細分市場，可以發現清晰的多維度需求促進因素和創新路徑。從組件分析來看，該行業正在大力投資感測器開發，以提高準確性，同時監測器和接收器也已發展到支援高級警報演算法並與行動應用程式整合。負責無線資料中繼的發射器模組繼續受益於低能耗通訊協定，從而延長電池壽命並減少維護干預。

了解美洲、中東和非洲以及亞太市場持續血糖監測的區域差異和成長潛力

區域差異在影響連續血糖監測系統的採用率、報銷策略和產品供應方面發揮關鍵作用。在美洲，強大的醫療基礎設施和支持性報銷政策使主要經濟體成為下一代設備的早期採用者。該地區的臨床醫生擴大將遠端監測納入標準治療通訊協定，報銷改革也正在擴大長期穿戴式感測器和整合分析平台的適用範圍。

分析推動持續血糖監測系統領先供應商發展的策略性舉措、產品創新和合作

領先的持續血糖監測系統供應商正在利用產品創新、策略聯盟和定向收購來保持競爭優勢。感測器技術先驅正在改進其演算法以提供預測警報，而其他供應商則專注於無縫平台整合，以提高與電子健康記錄和遠端醫療服務的互通性。設備製造商和軟體開發人員之間的合作正在創建端到端解決方案，將獨特的硬體與先進的數據視覺化和遠端指導模組相結合。

為產業領導者制定策略，以加速血糖監測的採用，改善患者體驗，並最佳化供應鏈彈性

尋求利用不斷發展的動態的行業領導者應優先將高級分析技術整合到其監測平台中。整合人工智慧和機器學習演算法可以幫助醫療服務提供者提高患者依從性，並提供個人化洞察，從而支援遠距臨床決策支援。同時，擴大與遠端保健平台和電子健康記錄供應商的夥伴關係，可以進一步鞏固持續血糖監測在綜合護理路徑中的作用。

為確保持續血糖監測洞察的穩健數據收集、分析和檢驗採用的嚴格調查方法框架的詳細資訊

本分析所採用的調查方法整合了原廠藥和二手藥研究，以確保定性洞察的深度和準確性。原廠藥研究包括與關鍵意見領袖、內分泌科醫生、糖尿病教育工作者和採購經理進行結構化訪談，以檢驗新興趨勢和營運挑戰。這些討論為臨床應用時間表、使用者偏好和區域報銷細則提供了背景資訊。

我們摘要了關鍵的觀察結果和未來的考慮，指南相關人員應對持續血糖監測系統不斷發展的格局

本執行摘要揭示了影響連續血糖監測系統的多方面因素，從技術突破和關稅影響，到細分市場和區域動態。關鍵觀察結果表明，設備創新不僅取決於感測器精度，還取決於連接性、使用者體驗和供應鏈穩健性。同時，不斷變化的貿易政策凸顯了對敏捷製造和多元化分銷網路的需求。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 人工智慧演算法整合用於CGM系統中的預測血糖控制
  • 擴展 CGM 平台，使其能夠與胰島素幫浦和數位健康應用程式互通
  • 長期穿戴式連續血糖監測儀微創感測器技術的開發
  • 採用非酵素葡萄糖感測方法提高了感測器的穩定性並減少了校準。
  • 實施雲端基礎的數據分析和遠端醫療整合，實現即時病患監測
  • 雙激素輸送系統與 CGM 結合，實現自動血糖調節
  • 以患者為中心的設計，採用靈活的貼片和長佩戴的感測器，正變得越來越重要
  • 監管部門的核准加速了下一代植入式 CGM 設備的普及
  • CGM製造商與製藥公司建立策略聯盟，實現糖尿病個人化治療
  • 感測器小型化和奈米技術的進步提高了準確性並降低了侵入性

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 持續血糖監測系統市場（按組件）

  • 接收器/監視器
  • 感應器
  • 發送器

9. 持續血糖監測系統市場（依設備類型）

  • 整合 CGM 系統
  • 獨立 CGM 系統

10. 持續血糖監測系統市場（依使用時長）

  • 長期植入式連續血糖監測
  • 短期穿戴式CGM

11. 持續血糖監測系統市場（依患者年齡層）

  • 成人
  • 孩子
  • 老年人

第 12 章：連續血糖監測系統市場（依應用）

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

13. 持續血糖監測系統市場（依分銷管道）

  • 離線
  • 線上
    • 電商平台
    • 製造商網站

第 14 章。持續血糖監測系統市場（按最終用戶）

  • 門診手術中心
  • 居家照護環境
  • 醫院和診所
    • 住院藥房
    • 門診藥房

15. 美國連續血糖監測系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16. 歐洲、中東和非洲連續血糖監測系統市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

17. 亞太地區持續血糖監測系統市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第18章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • A. Menarini Diagnostics srl
    • Abbott Laboratories
    • AgaMatrix Inc. by I-Sens Inc.
    • Ascensia Diabetes Care Holdings AG
    • Dexcom, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Insulet Corporation
    • Johnson & Johnson Services, Inc.
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • NXP Semiconductors NV
    • Senseonics Holdings Inc.
    • Sibionics
    • Signos, Inc.
    • STMicroelectronics NV
    • Tandem Diabetes Care, Inc.
    • Texas Instruments Incorporated
    • Ypsomed Holding AG

第19章 研究人工智慧

第20章 研究統計

第21章 研究聯絡人

第22章 研究報導

第23章 附錄

Product Code: MRR-43676CF422F8

The Continuous Glucose Monitoring Systems Market was valued at USD 4.47 billion in 2024 and is projected to grow to USD 4.79 billion in 2025, with a CAGR of 7.26%, reaching USD 6.82 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.47 billion
Estimated Year [2025] USD 4.79 billion
Forecast Year [2030] USD 6.82 billion
CAGR (%) 7.26%

Exploring the Emergence of Continuous Glucose Monitoring Systems as a Pivotal Force Shaping Modern Diabetes Management Practices Globally

In recent years, continuous glucose monitoring systems have redefined chronic disease management by providing uninterrupted, real time tracking of glycemic levels. This evolution has shifted the paradigm from episodic fingerstick testing to a continuous data driven approach, enabling clinicians and patients to identify trends, anticipate fluctuations, and intervene proactively. As diabetes prevalence continues to rise, pressure mounts on healthcare providers to deliver personalized, responsive care that mitigates complications and enhances quality of life.

Amidst this backdrop, technological breakthroughs in sensor accuracy, wireless communication, and user interface design have accelerated adoption among diverse patient populations. Regulatory bodies have responded by refining approval pathways and reimbursement guidelines, fostering an environment where novel devices can transition more swiftly from conception to clinical use. At the same time, integration with digital health platforms and telemedicine services has created new opportunities to collect, analyze, and apply glycemic data within holistic care frameworks.

As we embark on this exploration of system dynamics, it is essential to appreciate how stakeholder collaboration, patient empowerment, and technological innovation converge to shape an ecosystem that supports continuous monitoring. This introduction establishes the context for subsequent analysis, setting the stage for an examination of transformative shifts, tariff influences, segmentation nuances, regional variations, corporate strategies, and actionable recommendations that define today's continuous glucose monitoring landscape.

Unveiling Groundbreaking Advancements and Integrative Technologies Revolutionizing Real Time Glucose Monitoring for Enhanced Patient Outcomes

The landscape of glucose monitoring is undergoing a profound transformation as sensor miniaturization, cloud connectivity, and predictive algorithms converge. Modern devices no longer operate in isolation; they integrate seamlessly with smartphones, cloud databases, and remote monitoring platforms, allowing healthcare teams to respond in near real time. This shift toward continuous interoperability has unlocked new pathways for data analytics, yielding insights that guide therapy adjustments and reduce the risk of acute glycemic events.

Concurrently, breakthroughs in biocompatible materials and energy harvesting techniques have extended sensor lifespans, reducing patient burden and improving long term adherence. Miniature electrodes and advanced polymers now enable implantable systems to function for months without replacement, while wearable patches continue to evolve in shape and form factor to maximize comfort and discretion. Furthermore, artificial intelligence is being harnessed to forecast glycemic excursions, delivering automated alerts that preempt dangerous hypo- or hyperglycemia.

Together, these developments signal a move away from reactive care and toward proactive disease management. Patients are empowered to interpret personalized glucose patterns, clinicians can optimize therapy regimens with unprecedented precision, and payers benefit from reduced hospitalization rates. As we examine how these innovations reshape practice models, the broader implication is clear: glucose monitoring is no longer a diagnostic exercise, but a continuous dialogue between patient, clinician, and technology ecosystem.

Assessing the Impact of Enhanced Tariff Measures on the Cost and Supply Chain Dynamics of Continuous Glucose Monitoring Systems in the United States

The introduction of revised tariff measures in 2025 has brought supply chain fragility to the forefront of continuous glucose monitoring system distribution. Increased import duties on key components, including microelectronic sensors and wireless transceivers, have injected cost pressures into manufacturing pipelines. In response, several suppliers have diversified sourcing strategies, relocating production facilities closer to end markets and negotiating alternative raw material contracts to mitigate freight and duty escalations.

Amidst rising input costs, distributors and healthcare providers have sought to manage affordability concerns by consolidating procurement volumes and revising contract structures. Strategic collaborations between device manufacturers and logistics partners now emphasize inventory optimization and transparent cost pass through, aiming to preserve accessibility for patients who depend on uninterrupted glucose monitoring. At the same time, regulatory authorities are reassessing reimbursement frameworks to accommodate incremental pricing adjustments tied to tariff fluctuations.

Through these adaptations, the industry is demonstrating resilience in the face of policy shifts that could otherwise impede supply continuity. While short term adjustments in pricing tiers and contract terms may be necessary, the long term emphasis remains on fostering stable distribution channels and ensuring that device availability aligns with patient needs. This section highlights the interplay between trade policy and operational strategy, underscoring how tariff landscapes will continue to influence system deployment across the United States.

Delving into Market Segmentation Structured Across Components, Device Types, Usage Durations, Patient Demographics, Applications, and Distribution Channels

A granular examination of continuous glucose monitoring system segmentation reveals distinct demand drivers and innovation pathways across multiple dimensions. When considering component analysis, the industry has witnessed robust investment in sensor development to improve precision, while monitors and receivers have evolved to support advanced alert algorithms and integration with mobile applications. Transmitter modules, responsible for wireless data relay, continue to benefit from low energy consumption protocols that extend battery life and reduce maintenance interventions.

From the perspective of device type, integrated systems that combine sensor and transmitter within a unified wearable platform are gaining traction among patients seeking streamlined form factors. In parallel, standalone systems remain relevant for users who prefer modular configurations or who require rapid sensor replacement without altering monitor infrastructure. Duration of use also differentiates solutions, with long term implantable systems offering discrete, extended wear for patients with demanding adherence requirements, and short term wearable patches providing flexible options for intermittent monitoring or clinical trial settings.

Patient age group segmentation underscores unique user needs. Adult populations drive demand for sophisticated analytics and integration with digital health suites, whereas pediatric and geriatric cohorts prioritize simplicity of use and minimal skin irritation. Application segments further delineate system optimization strategies, as gestational diabetes monitoring calls for compact, easy to manage devices, type 1 diabetes management emphasizes insulin dosing accuracy, and type 2 diabetes patients often require intuitive interfaces that promote lifestyle modifications.

Distribution channel analysis highlights a dual track of offline channels-specialty clinics, pharmacies, and medical device distributors-and online avenues that span both third party eCommerce platforms and manufacturer websites. End user settings range from ambulatory surgical centers deploying perioperative monitoring solutions to home care environments favoring plug-and-play devices, as well as hospitals and clinics that rely on in-house pharmacy networks, including inpatient and outpatient pharmacies, to supply critical components. This segmentation framework illuminates where value creation and competitive differentiation converge across the continuous glucose monitoring ecosystem.

Uncovering Regional Variances and Growth Potential in Continuous Glucose Monitoring Across Americas, Europe Middle East Africa, and Asia Pacific Markets

Regional variation plays a pivotal role in shaping adoption rates, reimbursement strategies, and product offerings for continuous glucose monitoring systems. In the Americas, robust healthcare infrastructure and supportive reimbursement policies have positioned key economies as early adopters of next generation devices. Clinicians in this region increasingly incorporate remote monitoring into standard care protocols, and reimbursement reforms are expanding coverage for extended wear sensors and integrated analytics platforms.

Contrastingly, Europe, the Middle East, and Africa present a mosaic of regulatory frameworks and purchasing power dynamics. Western European countries benefit from centralized health technology assessments that streamline market access, whereas emerging markets in Eastern Europe and the Middle East navigate evolving reimbursement guidelines and logistical constraints. Across Africa, distribution challenges and limited healthcare budgets necessitate cost efficient solutions, sparking interest in partnerships that localize manufacturing and training programs to support clinical adoption.

In the Asia Pacific region, rapid urbanization, escalating diabetes prevalence, and expanding private healthcare expenditures are driving demand for portable, user friendly monitoring solutions. Markets such as Japan and Australia are characterized by early integration of digital health services, while Southeast Asian economies are fostering tiered access models that prioritize affordability and basic functionality. Interregional collaborations and technology transfer initiatives are further accelerating penetration in underserved areas, creating a dynamic environment where regional insights inform global market strategies.

Analyzing the Strategic Movements, Product Innovations, and Collaborations Driving Leading Continuous Glucose Monitoring System Providers Forward

Leading providers of continuous glucose monitoring systems are leveraging product innovation, strategic alliances, and targeted acquisitions to maintain competitive advantage. Pioneers in sensor technology are refining algorithms to deliver predictive alerts, while others focus on seamless platform integration to enhance interoperability with electronic health records and telemedicine services. Joint ventures between device manufacturers and software developers have resulted in end to end solutions that pair proprietary hardware with advanced data visualization and remote coaching modules.

Innovation pipelines are supported by collaborations with academic institutions and healthcare organizations, where real world evidence studies validate device performance across diverse patient cohorts. Intellectual property portfolios are expanded through filings in emerging geographies, ensuring that patented sensor chemistries and wireless protocols are protected globally. Simultaneously, select participants have pursued strategic acquisitions of complementary technology firms to fill product portfolio gaps and accelerate time to market.

In addition to technology partnerships, several providers are optimizing their commercial footprints through enhanced distribution agreements and logistics alliances. These collaborations streamline inventory management, reduce lead times, and support targeted marketing initiatives that educate clinicians and patients on system benefits. The combined effect of these strategic movements is a robust competitive landscape where leadership is defined by both technological differentiation and executional excellence.

Formulating Strategies for Industry Leaders to Accelerate Adoption, Enhance Patient Experience, and Optimize Supply Chain Resilience in Glucose Monitoring

Industry leaders seeking to capitalize on evolving dynamics should prioritize integration of advanced analytics into monitoring platforms. By embedding artificial intelligence and machine learning algorithms, providers can offer personalized insights that improve patient compliance and support remote clinical decision support. Simultaneously, expanding partnerships with telehealth platforms and electronic medical record vendors will cement the role of continuous glucose monitoring in comprehensive care pathways.

To address supply chain vulnerabilities exposed by recent tariff adjustments, organizations should diversify manufacturing locations and develop redundancy protocols for critical components. Engaging with contract development and manufacturing organizations in multiple regions can mitigate disruptions, while negotiating flexible contractual terms with logistics partners will enable rapid response to policy changes. Furthermore, adopting value based pricing models in collaboration with payers can preserve device affordability and secure long term reimbursement commitments.

Patient engagement strategies should be enhanced through user centric design and robust educational programs. Co-creating device features with end users and clinicians will ensure that form factors and interface designs resonate with target demographics. Lastly, ongoing investment in real world evidence generation will strengthen clinical value propositions, support regulatory approvals in new markets, and reinforce stakeholder confidence in system efficacy.

Detailing the Rigorous Methodological Framework Employed to Ensure Robust Data Collection, Analysis, and Validation for Continuous Glucose Monitoring Insights

The research methodology underpinning this analysis combines primary qualitative insights with comprehensive secondary data synthesis to ensure depth and accuracy. Primary research involved structured interviews with key opinion leaders, endocrinologists, diabetes educators, and procurement managers to validate emerging trends and operational challenges. These discussions provided context on clinical adoption timelines, user preferences, and regional reimbursement nuances.

Secondary research encompassed a review of regulatory filings, public company disclosures, industry white papers, and scientific literature to triangulate findings and map technological trajectories. Data extraction focused on device approvals, patent activity, key partnership announcements, and tariff policy documentation. This process was augmented by a meticulous assessment of logistical and distribution frameworks across major healthcare markets.

Throughout the study, a cross functional analytical framework was applied to segment insights by component, device type, usage duration, patient demographics, application, distribution channel, and end user setting. Regional analyses were informed by health technology assessments and national reimbursement guidelines. Finally, all findings underwent multi stage validation with subject matter experts to eliminate bias and confirm relevance for stakeholders across product development, commercialization, and policy domains.

Summarizing Critical Observations and Future Considerations to Guide Stakeholders in Navigating the Evolving Landscape of Continuous Glucose Monitoring Systems

This executive summary has illuminated the multifaceted forces shaping continuous glucose monitoring systems, from technological breakthroughs and tariff influences to granular segmentation and regional dynamics. Critical observations reveal that device innovation is not solely defined by sensor accuracy, but also by connectivity, user experience, and supply chain robustness. At the same time, shifting trade policies underscore the need for agile manufacturing and diversified distribution networks.

Segmentation insights highlight distinct value levers across patient cohorts, application types, and channel preferences, informing how providers can tailor solutions to meet unique clinical and consumer demands. Regional analyses demonstrate that while high income markets prioritize integration and reimbursement alignment, emerging economies are ripe for cost efficient offerings and local manufacturing initiatives. Meanwhile, leading companies continue to differentiate through strategic partnerships, intellectual property expansion, and customer centric commercialization strategies.

Looking ahead, stakeholders must balance innovation with operational resilience, embracing data driven decision making and collaborative frameworks that span technology vendors, healthcare providers, and payers. By synthesizing these strategic imperatives, organizations will be well positioned to navigate an evolving landscape that places continuous monitoring at the heart of diabetes management and preventive care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of artificial intelligence algorithms for predictive glucose management in CGM systems
  • 5.2. Expansion of interoperable CGM platforms with insulin pumps and digital health applications
  • 5.3. Development of minimally invasive sensor technologies for extended wear continuous glucose monitors
  • 5.4. Adoption of non-enzymatic glucose sensing methods to enhance sensor stability and reduce calibration
  • 5.5. Implementation of cloud-based data analytics and telehealth integration for real-time patient monitoring
  • 5.6. Emergence of dual-hormone delivery systems combined with CGM for automated glucose regulation
  • 5.7. Growing emphasis on patient-centric design with flexible patches and extended wear sensors
  • 5.8. Regulatory approvals accelerating availability of next-generation implantable CGM devices
  • 5.9. Strategic partnerships between CGM manufacturers and pharma companies to personalize diabetes therapies
  • 5.10. Advances in sensor miniaturization and nanotechnology to improve accuracy and reduce invasiveness

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Continuous Glucose Monitoring Systems Market, by Component

  • 8.1. Introduction
  • 8.2. Receivers/Monitors
  • 8.3. Sensors
  • 8.4. Transmitters

9. Continuous Glucose Monitoring Systems Market, by Type of Device

  • 9.1. Introduction
  • 9.2. Integrated CGM Systems
  • 9.3. Standalone CGM Systems

10. Continuous Glucose Monitoring Systems Market, by Duration of Use

  • 10.1. Introduction
  • 10.2. Long-Term Implantable CGMs
  • 10.3. Short-Term Wearable CGMs

11. Continuous Glucose Monitoring Systems Market, by Patient Age Group

  • 11.1. Introduction
  • 11.2. Adults
  • 11.3. Children
  • 11.4. Geriatric

12. Continuous Glucose Monitoring Systems Market, by Application

  • 12.1. Introduction
  • 12.2. Gestational Diabetes
  • 12.3. Type 1 Diabetes
  • 12.4. Type 2 Diabetes

13. Continuous Glucose Monitoring Systems Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Offline
  • 13.3. Online
    • 13.3.1. eCommerce Platforms
    • 13.3.2. Manufacturer Websites

14. Continuous Glucose Monitoring Systems Market, by End User

  • 14.1. Introduction
  • 14.2. Ambulatory Surgical Centers
  • 14.3. Home Care Settings
  • 14.4. Hospitals & Clinics
    • 14.4.1. Inpatient Pharmacies
    • 14.4.2. Outpatient Pharmacies

15. Americas Continuous Glucose Monitoring Systems Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Continuous Glucose Monitoring Systems Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. A. Menarini Diagnostics s.r.l
    • 18.3.2. Abbott Laboratories
    • 18.3.3. AgaMatrix Inc. by I-Sens Inc.
    • 18.3.4. Ascensia Diabetes Care Holdings AG
    • 18.3.5. Dexcom, Inc.
    • 18.3.6. F. Hoffmann-La Roche Ltd.
    • 18.3.7. Insulet Corporation
    • 18.3.8. Johnson & Johnson Services, Inc.
    • 18.3.9. Medtronic PLC
    • 18.3.10. Medtrum Technologies Inc.
    • 18.3.11. Nemaura Medical Inc.
    • 18.3.12. Novo Nordisk A/S
    • 18.3.13. NXP Semiconductors N.V.
    • 18.3.14. Senseonics Holdings Inc.
    • 18.3.15. Sibionics
    • 18.3.16. Signos, Inc.
    • 18.3.17. STMicroelectronics N.V.
    • 18.3.18. Tandem Diabetes Care, Inc.
    • 18.3.19. Texas Instruments Incorporated
    • 18.3.20. Ypsomed Holding AG

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHAI
  • FIGURE 30. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHSTATISTICS
  • FIGURE 31. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHCONTACTS
  • FIGURE 32. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS/MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS/MONITORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED CGM SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED CGM SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STANDALONE CGM SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STANDALONE CGM SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LONG-TERM IMPLANTABLE CGMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LONG-TERM IMPLANTABLE CGMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SHORT-TERM WEARABLE CGMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SHORT-TERM WEARABLE CGMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 92. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 94. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 96. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 102. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 111. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 112. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 113. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 114. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 115. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 116. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 117. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 119. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 122. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 129. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 130. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 131. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 132. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 133. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 134. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 135. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 139. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 140. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 141. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 142. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 143. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 147. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 148. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 149. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 150. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 151. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 152. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 153. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 155. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 159. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 160. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 161. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 163. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 164. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 165. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 166. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 167. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 168. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 169. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 170. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 171. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 173. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 175. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 176. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 177. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 178. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 179. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 182. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 221. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 222. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 223. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 224. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 225. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 226. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 227. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 229. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 231. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 233. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 234. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 235. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 237. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 238. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 239. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 240. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 241. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 242. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 243. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 244. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 245. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 247. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 249. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 251. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 252. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 253. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 255. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 256. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 257. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 258. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 259. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 260. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 261. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 262. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 263. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 265. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 267. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 269. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
  • TABLE 270. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
  • TABLE 271. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 273. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 274. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 275. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 276. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 277. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
  • TABLE 278. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
  • TABLE 279. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
  • TABLE 280. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
  • TABLE 281. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 283. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 285. ITALY CONTINU